Variant report

Variant	nsv1046807
Chromosome Location	chr10:118105880-118162086
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:118148115..118150598-chr10:118156074..118158218,2	MCF-7	breast:
2	chr10:118091784..118093842-chr10:118107566..118109369,2	MCF-7	breast:
3	chr10:118120948..118123709-chr10:118126113..118128028,2	MCF-7	breast:
4	chr10:118032107..118033940-chr10:118141449..118143332,2	MCF-7	breast:
5	chr10:118032605..118034992-chr10:118143839..118146449,3	MCF-7	breast:
6	chr10:118148115..118150598-chr10:118156074..118158218,2	MCF-7	breast:
7	chr10:118120948..118123709-chr10:118126113..118128028,2	MCF-7	breast:
8	chr10:118146381..118146912-chr13:35200018..35200859,2	MCF-7	breast:
9	chr10:118145824..118146402-chr10:118249094..118249846,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000151892	chromatin interactions

Extended variants
information (count: 891 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:891 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs376447890	chr10:118109203-118109204	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs559732485	chr10:118109214-118109215	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs372715281	chr10:118109245-118109246	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs182599360	chr10:118109282-118109283	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs548145819	chr10:118109334-118109335	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs367653086	chr10:118109404-118109405	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs574387715	chr10:118109426-118109427	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs146309935	chr10:118109433-118109434	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs186790514	chr10:118109484-118109485	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs375405391	chr10:118109491-118109492	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs139588741	chr10:118109550-118109551	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs534342276	chr10:118109567-118109568	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs372498142	chr10:118109608-118109609	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs528971681	chr10:118109642-118109643	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs144308415	chr10:118109678-118109679	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs146241310	chr10:118109696-118109697	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs554916819	chr10:118109698-118109699	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs550294815	chr10:118109712-118109713	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs576597676	chr10:118109776-118109777	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs139346090	chr10:118109883-118109884	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs559122365	chr10:118109901-118109902	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs577413235	chr10:118109903-118109904	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs568688531	chr10:118109911-118109912	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs541479496	chr10:118109959-118109960	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs142672536	chr10:118109960-118109961	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs539269489	chr10:118109972-118109973	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs191924859	chr10:118110036-118110037	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs369541732	chr10:118110085-118110086	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs184108980	chr10:118110102-118110103	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs2568925	chr10:118110137-118110138	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs530771016	chr10:118110145-118110146	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs207471481	chr10:118110146-118110147	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs115564484	chr10:118110152-118110153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs5788156	chr10:118110196-118110197	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs199747183	chr10:118110199-118110200	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs563882923	chr10:118110202-118110203	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs528162001	chr10:118110212-118110213	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs151017141	chr10:118110217-118110218	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs545551030	chr10:118110235-118110236	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs192947109	chr10:118110260-118110261	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs11197634	chr10:118110356-118110357	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs149657400	chr10:118110357-118110358	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs116798489	chr10:118110389-118110390	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs537688419	chr10:118110397-118110398	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs192134070	chr10:118113002-118113003	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs141585794	chr10:118113082-118113083	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs566487871	chr10:118113086-118113087	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs533846435	chr10:118113087-118113088	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs555605875	chr10:118113187-118113188	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs183342669	chr10:118113193-118113194	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Prostate cancer	18632612	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Lung cancer	18438408	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	20729466	CNVD
Paraganglioma	17535989	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Pulmonary chondroma	17535989	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	17387387	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	16608533	CNVD
small cell lung cancer	20016488	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	17393978	CNVD
Ovarian cancer	21720365	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cornelia de Lange syndrome	24599119	CNVD
T-cell lymphomas	19863542	CNVD
Breast cancer	16397240	CNVD
Urothelial carcinoma	21177765	CNVD
Chronic lymphocytic leukemia	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hepatocellular carcinoma	16750200	CNVD
Barrett''s syndrome	19417022	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Neuroticism	17667963	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Autism	21865298	CNVD

Chromatin state (count:89 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:118109200-118110400	Weak transcription	Fetal Brain Male	brain
2	chr10:118109400-118110000	Enhancers	HUES6 Cell Line	embryonic stem cell
3	chr10:118113000-118113800	Enhancers	HMEC	breast
4	chr10:118113000-118114400	Enhancers	NHEK	skin
5	chr10:118113200-118114000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
6	chr10:118113400-118113800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr10:118124000-118124800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
8	chr10:118124400-118124800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr10:118129200-118129400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
10	chr10:118129800-118130600	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr10:118130600-118131000	Weak transcription	HUES48 Cell Line	embryonic stem cell
12	chr10:118131000-118131200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr10:118131000-118131600	Enhancers	HUES48 Cell Line	embryonic stem cell
14	chr10:118131200-118131600	Enhancers	ES-I3 Cell Line	embryonic stem cell
15	chr10:118131200-118131600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr10:118131200-118131800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr10:118131200-118131800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
18	chr10:118131200-118131800	Active TSS	Muscle Satellite Cultured Cells	--
19	chr10:118131200-118132200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr10:118131400-118131800	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr10:118131400-118131800	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
22	chr10:118131400-118131800	Active TSS	Osteobl	bone
23	chr10:118131400-118132200	Enhancers	HSMM	muscle
24	chr10:118131600-118131800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr10:118131800-118132200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr10:118132000-118132400	Enhancers	Muscle Satellite Cultured Cells	--
27	chr10:118132400-118132600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
28	chr10:118139600-118139800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr10:118139800-118142000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
30	chr10:118142000-118144000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr10:118142200-118145000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
32	chr10:118142800-118143400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
33	chr10:118143000-118143800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr10:118143200-118143400	Enhancers	iPS-15b Cell Line	embryonic stem cell
35	chr10:118143200-118143600	Enhancers	Brain Germinal Matrix	brain
36	chr10:118143400-118144600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
37	chr10:118143600-118145200	Enhancers	HUES64 Cell Line	embryonic stem cell
38	chr10:118143800-118144200	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr10:118143800-118144200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr10:118143800-118144200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr10:118144200-118144600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr10:118144400-118144800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr10:118144400-118145000	Enhancers	ES-I3 Cell Line	embryonic stem cell
44	chr10:118144600-118145000	Enhancers	iPS-15b Cell Line	embryonic stem cell
45	chr10:118144800-118145200	Enhancers	HUES48 Cell Line	embryonic stem cell
46	chr10:118145200-118145600	Weak transcription	HUES48 Cell Line	embryonic stem cell
47	chr10:118145600-118145800	Enhancers	HUES48 Cell Line	embryonic stem cell
48	chr10:118145800-118149400	Weak transcription	HUES48 Cell Line	embryonic stem cell
49	chr10:118149200-118150200	Enhancers	iPS-18 Cell Line	embryonic stem cell
50	chr10:118149400-118150200	Enhancers	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links